Table 5.
Adjusted HRs, based on a Cox proportional hazards analysis of factors associated with incident eGFR<60 mL/min/1.73 m2
| p Value | HR | 95% CI |
||
|---|---|---|---|---|
| Age (years) | 0.019 | 1.030 | 1.005 | 1.056 |
| Baseline eGFR (mL/min/1.73 m2) | <0.001 | 0.957 | 0.944 | 0.971 |
| Body mass index (kg/m2) | 0.777 | 1.006 | 0.967 | 1.045 |
| Women (%) | 0.994 | 1.001 | 0.711 | 1.409 |
| Permanent AF (%) | 0.395 | 0.862 | 0.611 | 1.214 |
| Ankle-Brachial Index ≤0.90 (%) | 0.005 | 1.851 | 1.205 | 2.845 |
| Arterial hypertension (%) | 0.052 | 1.860 | 0.994 | 3.481 |
| Diabetes (%) | 0.151 | 0.713 | 0.449 | 1.132 |
| Heart failure (%) | 0.841 | 1.055 | 0.627 | 1.774 |
| History of stroke/TIA (%) | 0.867 | 1.046 | 0.619 | 1.767 |
| History of MI/CHD (%) | 0.172 | 0.725 | 0.457 | 1.150 |
| Antiplatelet (%) | 0.518 | 0.864 | 0.555 | 1.346 |
| ACE inhibitors/ARBs (%) | 0.442 | 0.842 | 0.543 | 1.306 |
| β blockers (%) | 0.788 | 1.052 | 0.728 | 1.521 |
| Calcium channel antagonists (%) | 0.029 | 0.640 | 0.429 | 0.954 |
| Statins (%) | 0.434 | 1.148 | 0.812 | 1.622 |
ACE, angiotensin converting enzyme; AF, atrial fibrillation; ARBs, angiotensin receptor blockers; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; TIA, transient ischaemic attack.